Hypermethylation of the CpG islands of the DKK1 promoter contributes to the absence of DKK1 expression in various tumors, including leukemia, and the DNA demethylating agent 5-aza-2-deoxycytidine reduces promoter methylation and restores DKK1 expression [30]. The gene discussed is DKK1; the disease is leukemia.